Trial of Liposomal Doxorubicin (Doxil) and Weekly Docetaxel (Taxotere)

NCT00183742 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Carcinoma

Interventions

DRUG: liposomal doxorubicin and docetaxel

Sponsor

University of Southern California

Collaborators

[object Object]